クリックして アクセシビリティに関する声明

人気検索

茶色の短髪にひげを生やし、眼鏡をかけた男性が、淡い青のブレザーと白いシャツを着て、無地の灰色の背景の前でカメラに向かって微笑んでいる——シカゴの弁護士や知的財産法専門家のプロフィール写真に最適。

ジェイソン・N・モック

パートナー

バック

ジェイソン・N・モック

パートナー

Washington, D.C. 202.295.4775

業務分野

教育

  • The George Washington University Law School (J.D., with honors)
    • Member, Federal Circuit Bar Journal
    • George S. Hastings IP Scholar
    • Finnegan Prize for Intellectual Property Law
  • University of Georgia (Ph.D., summa cum laude)
    • Pharmaceutical and biomedical science
  • University of Georgia (B.S., magna cum laude)
    • Biotechnology, and agricultural and applied economics

入学案内

  • コロンビア特別区
  • バージニア州
  • 米国特許商標庁

Dr. Jason Mock is an intellectual property attorney that helps organizations of all sizes in every facet of the patent life cycle. Whether a client is developing and obtaining new patent rights, managing a complex portfolio, performing due diligence for a transaction, or enforcing or defending its rights, Jason has the experience to guide his clients and serve as a trusted advisor.

Jason’s practice spans industries including pharmaceuticals, diagnostics, biotechnology, synthetic biology and biomanufacturing, food science, and agriculture. He has a depth of knowledge to help his clients keep pace in changing environments and realize value from their IP. Jason’s clients range from startups and universities to multinational corporations. He is a member of the firm’s Chemical, Biotechnology, & Pharmaceutical Practice and the PTAB Trials Practice.

プレゼンテーションと出版物

  • J. Mock, T. Yan, and K. Sharon, “IPR proactive defense measures – strategies and considerations for patent owners,” PTAB Trial Insights (May 2016)
  • J. Mock, “Split Federal Circuit Upholds Constitutionality of Single PTAB Panels Rendering Both Institution & Final Written Decisions,” PTAB Trial Insights (January 2016)
  • Author, “Post-Grant Proceedings at the USPTO and the Rising Tide of Federal Circuit Appeals,” The Federal Circuit Bar Journal (September 2015)
  • Co-author, “The Road Ahead for Kyle Bass’s IPRs,” Law360 (August 2015)
  • Co-author, “Will New PTAB Rules Impact IPRs Filed by Kyle Bass Hedge Fund?” The National Law Review (August 2015)
  • Co-author, “Survey of State Laws Against Bad-Faith Patent Assertion,” Bloomberg BNA Patent, Trademark & Copyright Journal (August 2014)
  • Co-author, “Role of the Phospholipase A2 Receptor in Liposome Drug Delivery in Prostate Cancer Cells,” Mol. Pharmaceuticals (2014)
  • Co-author, “Evidence for Distinct Mechanisms of Uptake and Antitumor Activity of Secretory Phospholipase A2 Responsive Liposomes in Prostate Cancer,” Integr. Biol. (2012)
  • Co-author, “Haloenol Pyranones and Morpholinones as Antineoplastic Agents of Prostate Cancer,” Bioorg. and Med. Chem. Letters (2012)
  • Co-author, “Secretory Phospholipase A2 Responsive Liposomes,” J. Pharm. Sci. (2011)
  • Co-author, Enhanced Antitumor Activity of Low-Dose Continuous Administration Schedules of Topotecan in Prostate Cancer,” Cancer Bio. and Therapy (2011)
2024年2月1日 プレスリリース

フォーリー、23人の新パートナーを発表

フォーリー＆ラードナー法律事務所は、2024年2月1日付で23名の弁護士をパートナーシップに選出した。
Assorted pills and capsules of various colors and shapes scattered on a blue background, with empty space on the left side, symbolizing complex cases that lawyers in Chicago or a corporate law office might handle.
2023年3月29日 今日の医療法

バイオ医薬品特許の崖：2023年とその先

パテントクリフ」とは、上市以来市場独占権を享受してきた医薬品の知的財産権保護が終了することを指す。様々な種類の規制上の独占権により、医薬品の保護期間が延長されることもあるが、一般的に医薬品が特許保護を失うと、ジェネリック医薬品の競合品が市場に出始める。
明るい背景に浮かぶ多数の半透明の青い球体のクローズアップ。右上にはフォーリー＆ラードナーLLPのロゴが配され、この一流企業法律事務所の革新的な精神を反映している。
2023年2月27日 今日の医療法

2023年のヘルスケア・ライフサイエンス分野のトップトレンド

フォーリーは、ヘルスケアおよびライフサイエンス企業のライフサイクルのあらゆる段階において、戦略的な助言を行うことができます。
August 19, 2020 Blogs

PTAB’s Motion to Amend Pilot Program: Review of Initial Results

We analyze the initial results of the pilot program for motions to amend ("MTA") and conclude that, while it is still early in development and subsequent results could lead to new insights, for now at least patent owners may be better off using alternative approaches such as reissue or ex parte reexamination.
March 31, 2020 Foley Viewpoints

COVID-19: Patent Procurement and Licensing

Public health officials have said that we can expect the coronavirus pandemic to last for months—and the underlying virus will likely be with us for the long term. Meanwhile, the response to the COVID-19 pandemic has included a flurry of innovation.
Empty courtroom with wooden desks and chairs, judge's bench at the front, American flag, and ornate wood paneling—a setting familiar to Chicago lawyers specializing in intellectual property law.
October 15, 2019 Blogs

While Tempting, PTAB Requests for Rehearing Face Long Odds

When the PTAB renders a decision, one of the parties is almost certain to be unhappy. Providing appropriate advice in the face of an undesired outcome requires an understanding of the odds of changing the outcome.
すべてのインサイトを見る
ニュースルームを見る